Overview

A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of V565 in participants with active Crohn's Disease.
Phase:
Phase 2
Details
Lead Sponsor:
VHsquared Ltd.